Home
>
National Drug Code (NDC)
>
Ximino
Ximino - 10631-330-05 - (minocycline hydrochloride)
Drug Information of Ximino
| Product NDC: | 10631-330 |
| Proprietary Name: | Ximino |
| Non Proprietary Name: | minocycline hydrochloride |
| Active Ingredient(s): | 45 mg/1 & nbsp; minocycline hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ximino
| Product NDC: | 10631-330 |
| Labeler Name: | Ranbaxy Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201922 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120901 |
Package Information of Ximino
| Package NDC: | 10631-330-05 |
| Package Description: | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-330-05) |
NDC Information of Ximino
| NDC Code | 10631-330-05 |
| Proprietary Name | Ximino |
| Package Description | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10631-330-05) |
| Product NDC | 10631-330 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | minocycline hydrochloride |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120901 |
| Marketing Category Name | NDA |
| Labeler Name | Ranbaxy Laboratories Inc. |
| Substance Name | MINOCYCLINE HYDROCHLORIDE |
| Strength Number | 45 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient] |
